首页> 外国专利> miRNA17-5p Biomarker microRNA17-5p for predict metastasis of colorectal cancer and uses thereof

miRNA17-5p Biomarker microRNA17-5p for predict metastasis of colorectal cancer and uses thereof

机译:用于预测结直肠癌转移的miRNA17-5p Biomarker microRNA17-5p及其用途

摘要

The present invention relates to a biomarker for predicting metastasis of colorectal cancer and its use, more specifically, a marker composition for predicting colorectal cancer metastasis, including microRNA17-5p (miRNA17-5p), measuring the expression level of the miRNA It relates to a composition for predicting colorectal cancer metastasis and a kit for predicting the colorectal cancer metastasis using the marker. By confirming that the miRNA17-5p according to the present invention directly binds to 3`UTR of Vimentin, an Epithelial Mesenchymal Transition (EMT)-related factor, which is an important process of metastasis in patients with colorectal cancer, and regulates expression, colon cancer is not It is expected to be useful as a biomarker for predicting metastasis to organs.
机译:预测大肠癌转移的生物标志物及其用途技术领域本发明涉及预测大肠癌转移的生物标志物及其用途,更具体地说,涉及测定miRNA的表达水平的微小RNA17-5p(miRNA17-5p)等预测大肠癌转移的标志物组合物。预测大肠癌转移的药物组合物和使用该标记物预测大肠癌转移的试剂盒。通过证实根据本发明的miRNA17-5p直接结合波形蛋白3'UTR,波形蛋白是一种与上皮间质转化(EMT)相关的因子,它是结直肠癌患者转移的重要过程,并调节表达,结肠癌症不是可以预期的。它有望作为预测器官转移的生物标志物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号